Technical Analysis for DAWN - Day One Biopharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New Downtrend | Bearish | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Inside Day | Range Contraction | -3.20% | |
Oversold Stochastic | Weakness | -3.20% | |
MACD Bearish Centerline Cross | Bearish | -1.83% | |
180 Bearish Setup | Bearish Swing Setup | -1.83% | |
Stochastic Reached Oversold | Weakness | -1.83% | |
Oversold Stochastic | Weakness | -1.83% | |
50 DMA Resistance | Bearish | -6.45% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 14 hours ago |
Outside Day | about 14 hours ago |
Fell Below Previous Day's Low | about 14 hours ago |
Rose Above Previous Day's High | about 15 hours ago |
Down 2 % | about 15 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/04/2024
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Enzymes Protein Kinase Inhibitor Signal Transduction Protein Kinase Kinase Fibrosarcoma Ym Biosciences
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Enzymes Protein Kinase Inhibitor Signal Transduction Protein Kinase Kinase Fibrosarcoma Ym Biosciences
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 18.67 |
52 Week Low | 9.67 |
Average Volume | 555,842 |
200-Day Moving Average | 13.26 |
50-Day Moving Average | 14.96 |
20-Day Moving Average | 15.56 |
10-Day Moving Average | 15.08 |
Average True Range | 0.82 |
RSI (14) | 38.65 |
ADX | 25.18 |
+DI | 15.38 |
-DI | 31.46 |
Chandelier Exit (Long, 3 ATRs) | 15.39 |
Chandelier Exit (Short, 3 ATRs) | 16.26 |
Upper Bollinger Bands | 17.68 |
Lower Bollinger Band | 13.44 |
Percent B (%b) | 0.12 |
BandWidth | 27.24 |
MACD Line | -0.19 |
MACD Signal Line | 0.11 |
MACD Histogram | -0.3026 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 14.95 | ||||
Resistance 3 (R3) | 15.06 | 14.82 | 14.78 | ||
Resistance 2 (R2) | 14.82 | 14.56 | 14.77 | 14.72 | |
Resistance 1 (R1) | 14.38 | 14.40 | 14.26 | 14.27 | 14.67 |
Pivot Point | 14.14 | 14.14 | 14.08 | 14.09 | 14.14 |
Support 1 (S1) | 13.70 | 13.88 | 13.58 | 13.59 | 13.19 |
Support 2 (S2) | 13.46 | 13.72 | 13.41 | 13.14 | |
Support 3 (S3) | 13.02 | 13.46 | 13.08 | ||
Support 4 (S4) | 12.91 |